MetaADEDB 2.0 @ LMMD
Silver
(BQCADISMDOOEFD-UHFFFAOYSA-N)
Structure
SMILES
[Ag]
Type(s)
Approved; Investigational
ATC code(s)
D08AL30
Molecular Formula:
Ag
Molecular Weight:
107.868
Log P:
0.0000
Hydrogen Bond Acceptor:
0
Hydrogen Bond Donor:
0
TPSA:
0
CAS Number(s):
7440-22-4; 69011-54-7
Synonym(s)
1.
Silver
External Link(s)
MeSHD012834
PubChem Compound23954
ChEBI30512
9141
DrugBankDB12965
KEGGcpd:C06710
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HeadacheFAERS: 1US FAERS
2MalaiseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
3Pharmaceutical product complaintFAERS: 1US FAERS
4Poor quality sleepFAERS: 1US FAERS
5Product contaminationFAERS: 1US FAERS
6Unevaluable eventFAERS: 1US FAERS
7AgranulocytosisSIDER
8Argyria16531870
27624343
CTD
9Autoimmune Diseases12743535CTD
10Bacterial colonisationSIDER
11Bacterial disease carrierSIDER
12Bile Duct Diseases19033393CTD
13Blood Platelet Disorders26996539CTD
14Burning sensationSIDER
15Cardiomegaly27417253CTD
16Cerebral Palsy16943593CTD
17Chemical and Drug Induced Liver Injury16531870
27346854
27417253
CTD
18Chromosome Breakage23804405
29462690
29703973
CTD
19Cognition Disorders29550386CTD
20DermatitisSIDER
21Dyspnea29632485CTD
22Edema25976698CTD
23Embryo Loss29964317CTD
24Erythema MultiformeSIDER
25Fetal Death29964317CTD
26Fetal Growth Retardation29964317CTD
27Hepatic necrosisSIDER
28HepatitisSIDER
29Hyperplasia19033393CTD
30HypersensitivitySIDER
31Immune System Diseases17996693CTD
32Inflammation17996693
19033393
29550386
CTD
33LeukopeniaSIDER
34Lung diseases19033393CTD
35Micronuclei, Chromosome-Defective24321264
27180073
27590928
CTD
36Necrosis22085606
24462830
27417253
CTD
37Nephritis, Interstitial27417253CTD
38NephrosisSIDER
39Nephrotic SyndromeSIDER
40Nerve Degeneration22240980CTD
41Neurobehavioral Manifestations29550386CTD
42Neurologic Manifestations26068065CTD
43Neurotoxicity Syndromes29782159CTD
44Partner stressSIDER
45Pericardial effusion29283201CTD
46Poisoning22954533CTD
47Prenatal Exposure Delayed Effects29550386CTD
48Prenatal Injuries25976698CTD
49Product container issueCanada Vigilance: 1Canada Vigilance
50Product label issueCanada Vigilance: 1Canada Vigilance
51Reaction gastrointestinalSIDER
52SepsisSIDER
53Skin necrosisSIDER
54Stevens-Johnson SyndromeSIDER
55ThrombocytopeniaSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.